167 related articles for article (PubMed ID: 23393366)
1. The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma.
Hsu CM; Yang MD; Tsai CW; Ho CY; Chang WS; Chang SC; Jeng LB; Tsai Y; Tsai FJ; Bau DT
Anticancer Res; 2013 Feb; 33(2):671-7. PubMed ID: 23393366
[TBL] [Abstract][Full Text] [Related]
2. Association of caveolin-1 genotypes with gastric cancer in Taiwan.
Lin CH; Lin CC; Tsai CW; Chang WS; Yang CW; Bau DT
Anticancer Res; 2014 May; 34(5):2263-7. PubMed ID: 24778029
[TBL] [Abstract][Full Text] [Related]
3. Significant association of caveolin-1 (CAV1) genotypes with upper urothelial tract cancer.
Chang WS; Lin SS; Li FJ; Tsai CW; Li LY; Lien CS; Liao WL; Wu HC; Tsai CH; Shih TC; Bau DT
Anticancer Res; 2013 Nov; 33(11):4907-12. PubMed ID: 24222128
[TBL] [Abstract][Full Text] [Related]
4. Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan.
Chang WS; Tsai CW; Wang SM; Wang SW; Wu HC; Ji HX; Lin CH; Wang ZH; Chou JC; Bau DT; Wang PS
Chin J Physiol; 2014 Aug; 57(4):220-6. PubMed ID: 25246063
[TBL] [Abstract][Full Text] [Related]
5. A novel caveolin-1 biomarker for clinical outcome of sarcopenia.
Lin CH; Lin CC; Tsai CW; Chang WS; Yang MD; Bau DT
In Vivo; 2014; 28(3):383-9. PubMed ID: 24815842
[TBL] [Abstract][Full Text] [Related]
6. The Relationship Between 6 Polymorphisms of Caveolin-1 Gene and the Risk of Breast Cancer.
Fard ZT; Nafisi N
Clin Breast Cancer; 2018 Oct; 18(5):e893-e898. PubMed ID: 29525429
[TBL] [Abstract][Full Text] [Related]
7. Significant association of caveolin-1 single nucleotide polymorphisms with childhood leukemia in Taiwan.
Wang CH; Lai YL; Chang WS; Wu KH; Lane HY; Chiu CF; Tsai FJ; Lin CC; Bau DT
Cancer Genomics Proteomics; 2013; 10(2):75-9. PubMed ID: 23603343
[TBL] [Abstract][Full Text] [Related]
8. The contribution of XRCC6/Ku70 to hepatocellular carcinoma in Taiwan.
Hsu CM; Yang MD; Chang WS; Jeng LB; Lee MH; Lu MC; Chang SC; Tsai CW; Tsai Y; Tsai FJ; Bau DT
Anticancer Res; 2013 Feb; 33(2):529-35. PubMed ID: 23393345
[TBL] [Abstract][Full Text] [Related]
9. Significant association of caveolin-1 (CAV1) genotypes with breast cancer in Taiwan.
Liu LC; Su CH; Wang HC; Tsai CW; Chang WS; Ho CY; Wu CI; Li FJ; Lin CH; Lane HY; Bau DT
Anticancer Res; 2011 Oct; 31(10):3511-5. PubMed ID: 21965771
[TBL] [Abstract][Full Text] [Related]
10. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
[TBL] [Abstract][Full Text] [Related]
11. Associations of genetic variants in the transcriptional coactivators EP300 and PCAF with hepatocellular carcinoma.
Akil A; Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; Diagne AG; Benjouad A; Dejean A; Pineau P; Benjelloun S
Cancer Epidemiol; 2012 Oct; 36(5):e300-5. PubMed ID: 22709982
[TBL] [Abstract][Full Text] [Related]
12. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma.
Weng CJ; Hsieh YH; Tsai CM; Chu YH; Ueng KC; Liu YF; Yeh YH; Su SC; Chen YC; Chen MK; Yang SF
Ann Surg Oncol; 2010 Jul; 17(7):1808-15. PubMed ID: 20119675
[TBL] [Abstract][Full Text] [Related]
13. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
[TBL] [Abstract][Full Text] [Related]
14. RASSF1A Ala133Ser polymorphism is associated with increased susceptibility to hepatocellular carcinoma in a Turkish population.
Bayram S
Gene; 2012 May; 498(2):264-9. PubMed ID: 22394463
[TBL] [Abstract][Full Text] [Related]
15. Significant association of caveolin-1 genotypes with bladder cancer susceptibility in Taiwan.
Bau DT; Chang CH; Tsai RY; Wang HC; Wang RF; Tsai CW; Yao CH; Chen YS; Shyue SK; Huang CY
Chin J Physiol; 2011 Jun; 54(3):153-60. PubMed ID: 21789897
[TBL] [Abstract][Full Text] [Related]
16. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
17. Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma.
Chen TY; Li YC; Liu YF; Tsai CM; Hsieh YH; Lin CW; Yang SF; Weng CJ
Ann Surg Oncol; 2011 Aug; 18(8):2348-56. PubMed ID: 21298348
[TBL] [Abstract][Full Text] [Related]
18. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
Bayram S; Akkız H; Bekar A; Akgöllü E
Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
[TBL] [Abstract][Full Text] [Related]
20. Functional polymorphisms of caveolin-1 variants as potential biomarkers of esophageal squamous cell carcinoma.
Wang S; Zhang C; Liu Y; Xu C; Chen Z
Biomarkers; 2014 Dec; 19(8):652-9. PubMed ID: 25271040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
